Anitra Fielding
- Oncology top 0.5%
- Molecular Biology top 5%
- Reproductive Medicine top 0.5%
- Genetics top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Michael FriedländerRonnie Shapira‐FrommerJonathan A. LedermannCharlie GourleyDarren HodgsonStuart SpencerGordon RustinUrsula A. Matulonis
- Topics
- PARP inhibition in cancer therapy (37 papers)BRCA gene mutations in cancer (22 papers)Ovarian cancer diagnosis and treatment (21 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Anitra Fielding
56 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 3.7k
- Molecular Biology 1.9k
- Reproductive Medicine 1.5k
- Genetics 1.1k
- Pulmonary and Respiratory Medicine 758
Countries citing papers authored by Anitra Fielding
This map shows the geographic impact of Anitra Fielding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anitra Fielding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anitra Fielding more than expected).
Fields of papers citing papers by Anitra Fielding
This network shows the impact of papers produced by Anitra Fielding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anitra Fielding. The network helps show where Anitra Fielding may publish in the future.
Co-authorship network of co-authors of Anitra Fielding
This figure shows the co-authorship network connecting the top 25 collaborators of Anitra Fielding. A scholar is included among the top collaborators of Anitra Fielding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anitra Fielding. Anitra Fielding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 54 | |
| 6 | 16 | |
| 7 | 1 | |
| 8 | 20 | |
| 9 | 23 | |
| 10 | 167 | |
| 11 | PHARMACOKINETICS AND SAFETY OF OLAPARIB IN PATIENTS WITH ADVANCED SOLID TUMORS AND HEPATIC OR RENAL IMPAIRMENT | 1 |
| 12 | Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer | 1 |
| 13 | 47 | |
| 14 | 83 | |
| 15 | 40 | |
| 16 | 14 | |
| 17 | 112 | |
| 18 | 19 | |
| 19 | 85 | |
| 20 | Effect of voriconazole on the pharmacokinetics of omeprazole | 2 |
About Anitra Fielding
Anitra Fielding is a scholar working on Reproductive Medicine, Oncology and Genetics, having authored 57 papers that have together received 5.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (37 papers), BRCA gene mutations in cancer (22 papers) and Ovarian cancer diagnosis and treatment (21 papers). The work is most often cited by research in Reproductive Medicine (1.5k citations), Oncology (3.7k citations) and Cancer Research (699 citations). Anitra Fielding has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Michael Friedländer, Ronnie Shapira‐Frommer, Jonathan A. Ledermann, Charlie Gourley, Darren Hodgson, Stuart Spencer, Gordon Rustin, Ursula A. Matulonis, Tamar Safra and Clare L. Scott. Their work appears in journals such as Journal of Clinical Oncology, The EMBO Journal and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.